News

Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate

Certificate of Suitability (CEP) for the API Levofloxacin Hemihydrate has been granted.

Dr. Reddy’s is among the first companies to receive the CEP from the European Directorate for the Quality of Medicines (EDQM). Together with our expanded manufacturing capacities, this makes us a reliable partner to support your oral and injectable formulations of this anti-infective.

Reach out to our API team at api@drreddys.com or submit an enquiry below to learn more.

Find out more about the product here:

https://api.drreddys.com/product/levofloxacin-hemihydrate

Email us: api@drreddys.com
+91 40 49002253

Contact Us

Please fill in the following form and we'll get back to you shortly.

* I agree and accept the Privacy Policy and Terms of Use of this website.

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.